Anastasios Gianakakos - Dec 29, 2021 Form 4 Insider Report for LianBio (LIAN)

Role
Director
Signature
By: /s/ Angela Chen, Attorney-in-Fact
Stock symbol
LIAN
Transactions as of
Dec 29, 2021
Transactions value $
$237,197
Form type
4
Date filed
1/3/2022, 03:20 PM
Previous filing
Oct 29, 2021
Next filing
Jun 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIAN Ordinary Shares Options Exercise $237K +36.5K $6.49 36.5K Dec 29, 2021 Direct
holding LIAN Ordinary Shares 310K Dec 29, 2021 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIAN Stock Option (Right to Buy) Options Exercise $0 -36.5K -25% $0.00 110K Dec 29, 2021 Ordinary Shares 36.5K $6.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option vested and became exercisable on the first anniversary of the commencement date, December 17, 2021; the remainder shall vest and become exercisable in 3 equal annual installments such that the option shall be fully vested on December 17, 2024, subject to the Reporting Person providing continuous service to the Issuer on each such date.